Lisa Boselli
Overview
Explore the profile of Lisa Boselli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
524
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Coutzac C, Jouniaux J, Paci A, Schmidt J, Mallardo D, Seck A, et al.
Nat Commun
. 2020 May;
11(1):2168.
PMID: 32358520
Gut microbiota composition influences the clinical benefit of immune checkpoints in patients with advanced cancer but mechanisms underlying this relationship remain unclear. Molecular mechanism whereby gut microbiota influences immune responses...
12.
Pitoiset F, Cassard L, El Soufi K, Boselli L, Grivel J, Roux A, et al.
Cytometry A
. 2018 Sep;
93(8):793-802.
PMID: 30168890
Multicolor flow cytometry is a technology of choice for phenotyping of immune cells, and it can be used routinely for the follow up of patients in clinical trials. But it...
13.
Coutzac C, Adam J, Soularue E, Collins M, Racine A, Mussini C, et al.
J Crohns Colitis
. 2017 Oct;
11(10):1238-1246.
PMID: 28967957
Background And Aim: Immune checkpoint inhibitors targeting CTLA-4 and PD-1 improve survival in cancer patients but may induce immune-related adverse events, including colitis. The immunological characteristics of anti-CTLA-4 [αCTLA-4]- and...
14.
Desbois M, Vu P, Coutzac C, Marcheteau E, Beal C, Terme M, et al.
J Immunol
. 2016 May;
197(1):168-78.
PMID: 27217584
Tumors with the help of the surrounding environment facilitate the immune suppression in patients, and immunotherapy can counteract this inhibition. Among immunotherapeutic strategies, the immunostimulatory cytokine IL-15 could represent a...